Two names on a day the Federal Reserve raised rates. The regime reading still says risk-on, but every leading sector is decelerating, only seven of 39 sectors carry positive momentum — the narrowest reading this desk has taken — and the trend scan fired eight sells against five buys. A third candidate was dropped on new evidence of our own, explained below.
The core scan, the signal screener, the breakout list and the sector table all refreshed this morning. Two feeds are missing: the rotation gem list is completely empty today, and the options-income tables carry yesterday's data, which is also where the market-regime figure comes from. There are no spread structures on this page as a result.
| Sector | Momentum | Accel | 1D | Read |
|---|---|---|---|---|
| Shipping · BOAT | +9.71 | −25.24 | −0.72% | Still first; momentum falling week over week |
| Cloud · SKYY | +5.97 | −31.07 | −1.37% | Fastest deceleration in the table |
| Commodities · DBC | +5.87 | −14.91 | +0.39% | Third |
| Software · IGV | +4.82 | −17.92 | −1.67% | Fourth |
| Energy · XLE | +2.89 | −14.45 | −0.18% | Back into the top five as others fade |
| Biotech · XBI | −1.03 | −22.05 | −0.92% | Negative momentum — today's top pick sits here |
Only seven of 39 sectors carry positive momentum and all five leaders are decelerating. The Federal Reserve raised rates this week, which shows up across the healthcare names as profit-taking after 52-week highs. This is a narrow, defensive tape.
The cleanest profile in the scan: Mansfield RS +121 and rising 26.6 this week, 21 weeks into Stage 2, TipRanks smart score 10 with a Strong Buy from both the full and the best-analyst panels, and the only finalist that is not overbought (RSI 65.8). It is also the rare name here trading below its average analyst target rather than above it, and insider activity is strongly positive. Counter-evidence: it is up 241% this year; its sector has negative momentum and is decelerating hard (−22); and Phase 2 data for ABCL635 is presented September 30th to October 3rd — outside the three-session earnings window but still a dated event that can move it either way.
Sits in Shipping, still the highest-momentum sector, with Mansfield RS +43.4, 54 weeks into Stage 2, and it appears on the signal screener's buy list. It made a new 52-week high yesterday leading the Oslo index, on a Q2 earnings beat and firm freight rates. Daily SATA (10) is above weekly (9), which is the shape of a name still accelerating. Counter-evidence: RSI 76.1, which the evidence below now says is a real cost; it trades above its analyst target; it is up 104% this year; and its sector, while first, is decelerating faster than any other in the table (−25.2).
Neither has a fresh timing crossover; both sit outside the 157-name universe that scan covers. A third slot was available and left empty.
No live spread data, so nothing is shown.
| Cohort | Mean alpha | Median | Beat SPY | Best | Worst |
|---|---|---|---|---|---|
| 2026-08-31 · 7 | +5.72% | −3.30% | 3/7 | CVI +29.8% | ESTC −11.2% |
| 2026-09-01 · 7 | −1.50% | −0.38% | 3/7 | VLO +15.6% | SLB −14.5% |
| 2026-09-02 · 3 | −8.67% | −10.42% | 0/3 | VET −4.1% | HP −11.5% |
| 2026-09-03 · 3 | −2.95% | −3.18% | 1/3 | CRGY +2.4% | ZYME −8.1% |
| 2026-09-08 · 3 | −2.33% | −1.44% | 0/3 | ELPC −0.6% | MTDR −5.0% |
| 2026-09-11 · 3 | +7.38% | +4.48% | 3/3 | TEN +13.4% | UROY +4.2% |
| 2026-09-15 · 3 | −4.13% | −2.37% | 0/3 | SUN −1.3% | SM −8.7% |
| 2026-09-16 · 2 | +0.61% | +0.61% | 1/2 | MPC +3.0% | LPG −1.8% |
| 2026-09-17 · 3 | −0.28% | +1.01% | 2/3 | TRMD +3.8% | IOVA −5.7% |
| All 34 | −0.06% | −1.60% | 13/34 | trimmed −0.77% · ex top two −1.59% | |
Total alpha across 34 picks is −2.2 points; CVI (+29.8) and TRMD (+18.8) contribute +48.6. Without them the other 32 average −1.59%, median −2.07%. Thirteen of 34 beat the index. Yesterday's three are mixed after one session: TRMD +3.8%, SMTC +1.0%, IOVA −5.7% — the biotech with RSI 77 at flag is the one that fell, which is consistent with the finding below.